Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>In cumulative Q3 FY01/26, the company reported no operating revenue and an operating loss of JPY2.7bn.</li><li>The company forecasts a recurring loss of JPY4.5bn and a net loss of JPY4.0bn for FY01/26.</li><li>R&D expenses increased to JPY2.8bn, reflecting sales preparation and manufacturing costs for AKUUGO® approval changes.</li></ul>

In cumulative Q3 FY01/26, the company reported no operating revenue and an operating loss of JPY2.7bn.The company forecasts a recurring loss of JPY4.5bn and a net loss of JPY4.0bn for FY01/26.R&D expenses increased to JPY2.8bn, reflecting sales preparation and manufacturing costs for AKUUGO® approval changes.

SanBio Co Ltd (4592 JP): Q3 FY01/26 flash update